Neckár Jan, Szárszoi Ondrej, Koten Lukás, Papousek Frantisek, Ost'ádal Bohuslav, Grover Gary J, Kolár Frantisek
Institute of Physiology, Academy of Sciences of the Czech Republic and Centre for Experimental Cardiovascular Research, Vídenská 1083, 142 20 Prague 4, Czech Republic.
Cardiovasc Res. 2002 Aug 15;55(3):567-75. doi: 10.1016/s0008-6363(02)00456-x.
Adaptation of rats to intermittent high altitude hypoxia increases the tolerance of their hearts to acute ischemia/reperfusion injury. Our aim was to examine the role of mitochondrial ATP-sensitive potassium channels (K(ATP)) in this form of protection.
Adult male Wistar rats were exposed to hypoxia of 5000 m in a barochamber for 8 h/day, 5 days a week; the total number of exposures was 24-32. A control group was kept under normoxic conditions (200 m). Infarct size (tetrazolium staining) was measured in anesthetized open-chest animals subjected to 20-min regional ischemia (coronary artery occlusion) and 4-h reperfusion. Isolated perfused hearts were used to assess the recovery of contractile function following 20-min global ischemia and 40-min reperfusion. In the open-chest study, a selective mitochondrial K(ATP) blocker, 5-hydroxydecanoate (5 mg/kg), or openers, diazoxide (10 mg/kg) or BMS-191095 (10 mg/kg), were administered into the jugular vein 5 and 10 min before occlusion, respectively. In the isolated heart study, 5-hydroxydecanoate (250 micromol/l) or diazoxide (50 micromol/l) were added to the perfusion medium 5 or 10 min before ischemia, respectively.
In the control normoxic group, infarct size occupied 62.2+/-2.0% of the area at risk as compared with 52.7+/-2.5% in the chronically hypoxic group (P<0.05). Post-ischemic recovery of contractile function (dP/dt) reached 60.0+/-3.9% of the pre-ischemic value and it was improved to 72.4+/-1.2% by adaptation to hypoxia (P<0.05). While 5-hydroxydecanoate completely abolished these protective effects of chronic hypoxia, it had no appreciable influence in normoxic groups. In contrast, diazoxide significantly increased the recovery of contractile function and reduced infarct size in normoxic groups only. The later effect was also observed following treatment with BMS-191095.
The results suggest that opening of mitochondrial K(ATP) channels is involved in the cardioprotective mechanism conferred by long-term adaptation to intermittent high altitude hypoxia.
使大鼠适应间歇性高海拔低氧环境可增强其心脏对急性缺血/再灌注损伤的耐受性。我们的目的是研究线粒体ATP敏感性钾通道(K(ATP))在这种保护形式中的作用。
成年雄性Wistar大鼠在气压舱中暴露于5000米的低氧环境,每天8小时,每周5天;暴露总次数为24 - 32次。对照组置于常氧条件下(200米)。在麻醉开胸动物中,通过20分钟的局部缺血(冠状动脉阻塞)和4小时的再灌注,测量梗死面积(四氮唑染色)。使用离体灌注心脏评估20分钟全心缺血和40分钟再灌注后收缩功能的恢复情况。在开胸研究中,分别在阻塞前5分钟和10分钟,将选择性线粒体K(ATP)阻滞剂5 - 羟基癸酸(5毫克/千克)或开放剂二氮嗪(10毫克/千克)或BMS - 191095(10毫克/千克)经颈静脉给药。在离体心脏研究中,分别在缺血前5分钟或10分钟,将5 - 羟基癸酸(250微摩尔/升)或二氮嗪(50微摩尔/升)加入灌注培养基中。
在对照常氧组中,梗死面积占危险区域的62.2±2.0%,而在慢性低氧组中为52.7±2.5%(P<0.05)。缺血后收缩功能的恢复(dP/dt)达到缺血前值的60.0±3.9%,通过适应低氧环境可提高到72.4±1.2%(P<0.05)。虽然5 - 羟基癸酸完全消除了慢性低氧的这些保护作用,但对常氧组没有明显影响。相反,二氮嗪仅在常氧组中显著增加了收缩功能的恢复并减小了梗死面积。用BMS - 191095治疗后也观察到了后一种效果。
结果表明,线粒体K(ATP)通道的开放参与了长期适应间歇性高海拔低氧环境所赋予的心脏保护机制。